Biotech Enzymatica AB Year-end report 2024: Strong performance in core markets – preparing for international growth February 18, 2025
Biotech Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer February 17, 2025
Biotech OraGen®, the first and only viable bone allograft, is now available for dental procedures February 16, 2025
Biotech Aramis Biotechnologies and the Biologics Manufacturing Centre Announce a Partnership February 15, 2025
Biotech DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development February 13, 2025
Biotech Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 February 12, 2025
Biotech Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China February 11, 2025
Biotech BioRay’s ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA February 10, 2025
Biotech AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE February 9, 2025